Peter David Suzdak
Directeur/Membre du Conseil chez Acidophil LLC
Provenance du réseau au premier degré de Peter David Suzdak
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
| Public Company | Pharmaceuticals: Major | 16 | |
| Extinct | Pharmaceuticals: Major | 12 | |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury
11
| Extinct | Pharmaceuticals: Major | 11 |
Acidophil LLC
 Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD.
6
| Private Company | Medical/Nursing Services | 6 |
National Institute of Mental Health
2
| Government | General Government | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter David Suzdak via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CARDINAL HEALTH, INC. | Medical Distributors | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor | |
| GENVEC INC | Pharmaceuticals: Major | Chief Executive Officer President | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| POLYMEDIX, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
AgriMetis LLC
 AgriMetis LLC BiotechnologyHealth Technology AgriMetis LLC operates a biotech company, which engages in the development of crop protection agents. It also offers natural products derived compounds to protect crops from weeds, fungal diseases, and insect pests. Its AgriMetis technology platform employs multidisciplinary and integrated scientific approach that allows access to areas of chemical space and production routes that are inaccessible to others. The company was founded by Philip Goelet, Simon Aspland and Brian Green in March 2014 and is headquartered in Lutherville, MD. | Biotechnology | Founder Founder Director of Finance/CFO | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Danfoss A/S
 Danfoss A/S Industrial MachineryProducer Manufacturing Danfoss A/S operates as an engineering company. The firm manufactures refrigeration, air conditioning, and industrial controls for several industries. Its products include thermostatic expansion valves, solenoid, pressure and temperature regulators, electronic controls, line components, electronically operated, coils, solenoid, pressure controls and thermostats, filter driers, sight glasses, contactors and motor starters, liquid level controls, condensing units, appliance, controls accessories and spare parts, compressors for air conditioning, heating and refrigeration, heat exchangers, and valve station. It operates through the following segments: Danfoss Power Solutions, Danfoss Climate Solutions, Danfoss Power Electronics and Drives, and Other Areas. The Danfoss Power Solutions segment establishes electric powertrain systems. The Danfoss Climate Solutions segment includes heating and cooling solutions for buildings, cold chains, industry, and infrastructure. The Danfoss Power Electronic and Drives segment focuses on the decarbonization with electric and energy solutions for vehicles and industry. The company was founded by Peter Johan Mads Clausen on September 1, 1933 and is headquartered in Nordborg, Denmark. | Industrial Machinery | Director/Board Member Director/Board Member | |
LEGO A/S
 LEGO A/S Recreational ProductsConsumer Durables LEGO A/S manufactures and markets play materials and toys. The firm offers preschool products, such as loose bricks, play themes, and educational toys for kindergarten toddlers, schoolchildren and teenagers. The company was founded by Ole Kirk Kristiansen in 1932 and is headquartered in Billund, Denmark. | Recreational Products | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
| Pohang University of Science & Technology | College/University | Graduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of South Florida | College/University | Undergraduate Degree Graduate Degree | |
| University of Aarhus | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Chairman Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
Hyundai Venture Investment Corp.
 Hyundai Venture Investment Corp. Investment ManagersFinance Hyundai Venture Investment Corp. (HVIC) is the venture capital arm of Hyundai Finance Corp., founded in 1997. The firm is headquartered in Seoul, South Korea. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Steno Diabetes Center A/S | Chairman Chairman Director/Board Member | ||
TheraTarget, Inc.
 TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Medical/Nursing Services | Founder Founder | |
| SANA AB | Biotechnology | Founder Founder | |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Antag Therapeutics ApS
 Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
KSV Global
 KSV Global Investment ManagersFinance KSV Global Innovations LP provides investment services. The company was founded by Dan Gay, Jon Gay, Ted Jeong, and Spencer Nam in 2018 and is headquartered in Boston, MA. | Investment Managers | Chief Executive Officer Consultant / Advisor | |
| CLENE INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO |
Statistiques
Internationale
| Danemark | 24 |
| Etats-Unis | 23 |
| Corée du Sud | 3 |
| Royaume-Uni | 2 |
| Norvège | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 407 |
| Corporate Officer/Principal | 197 |
| Chairman | 110 |
| Independent Dir/Board Member | 103 |
| President | 92 |
Relations les plus connectées
| Insiders | |
|---|---|
| Steven Paul | 39 |
| Jack Nielsen | 38 |
| Henrik Poulsen | 37 |
| Harry Penner | 31 |
| Anders Hedegaard | 30 |
| Claus Tycho Bræstrup | 27 |
| Bruce Carter | 25 |
| Anker Gunvald Lundemose | 25 |
| Jens Jesper Ovesen | 25 |
| Joseph Klein | 24 |
| Thomas Dyrberg | 24 |
| Lise Kingo | 23 |
| Mark P. Carthy | 23 |
| Carsten Hellmann | 22 |
| Amit Kumar | 21 |
- Bourse
- Insiders
- Peter David Suzdak
- Connexions Sociétés
